• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成本效益分析中社会贴现率的哲学渊源。

Philosophical origins of the social rate of discount in cost-benefit analysis.

作者信息

Robinson J C

机构信息

School of Public Health, University of California, Berkeley 94720.

出版信息

Milbank Q. 1990;68(2):245-65.

PMID:2122200
Abstract

The social rate of discount--that is, the way decision makers today evaluate future consequences of collective activity--raises difficult issues of intergenerational justice. When benefits are discounted at the present rate the United States government requires, serious efforts to promote public health over the long term will fail cost-benefit tests. No consensus exists among theorists to establish fair rates; philosophers support discounting with economic arguments that economists reject, while economists no less paradoxically support the concept using philosophical arguments that philosophers disavow. A new emphasis on the role of consumers' and citizens' time preferences, however, will keep open rather than close debates on the social discount rate.

摘要

社会贴现率——即当今决策者评估集体活动未来后果的方式——引发了代际正义的棘手问题。当按照美国政府要求的当前贴现率对收益进行贴现时,从长期促进公众健康的认真努力将通不过成本效益测试。理论家中不存在确定公平贴现率的共识;哲学家们用经济学家拒绝的经济论据支持贴现,而经济学家们同样自相矛盾地用哲学家否认的哲学论据支持这一概念。然而,对消费者和公民时间偏好作用的新强调将使关于社会贴现率的辩论保持开放而非结束。

相似文献

1
Philosophical origins of the social rate of discount in cost-benefit analysis.成本效益分析中社会贴现率的哲学渊源。
Milbank Q. 1990;68(2):245-65.
2
Philosophical origins of the economic valuation of life.生命经济价值评估的哲学起源。
Milbank Q. 1986;64(1):133-55.
3
Discounting in health care decision-making: time for a change?医疗保健决策中的贴现:是时候做出改变了吗?
J Public Health Med. 1992 Sep;14(3):250-6.
4
[The precautionary principle: advantages and risks].[预防原则:优势与风险]
J Chir (Paris). 2001 Apr;138(2):68-80.
5
Family pediatrics: report of the Task Force on the Family.家庭儿科学:家庭问题特别工作组报告
Pediatrics. 2003 Jun;111(6 Pt 2):1541-71.
6
[Economics and ethics in public health?].[公共卫生中的经济学与伦理学?]
Gesundheitswesen. 1999 Jan;61(1):1-7.
7
[Social and population policy. Considerations on efficiency and equity].[社会与人口政策。关于效率与公平的思考]
Demos. 1991(4):25-6.
8
Implementing and using quality measures for children's health care: perspectives on the state of the practice.实施和使用儿童保健质量指标:实践现状透视
Pediatrics. 2004 Jan;113(1 Pt 2):217-27.
9
Prevention, policy, and paradox: what is the value of future health?预防、政策与悖论:未来健康的价值何在?
Am J Prev Med. 1997 Jan-Feb;13(1):12-7.
10
Empiricism, ethics and orthodox economic theory: what is the appropriate basis for decision-making in the health sector?经验主义、伦理学与正统经济理论:卫生部门决策的恰当依据是什么?
Soc Sci Med. 2005 Jan;60(2):265-75. doi: 10.1016/j.socscimed.2004.04.034.

引用本文的文献

1
Discounting health gain: a different view.对健康收益的贴现:一种不同的观点。
J Mark Access Health Policy. 2023 Nov 2;11(1):2275350. doi: 10.1080/20016689.2023.2275350. eCollection 2023.
2
A review of management of infertility in Nigeria: framing the ethics of a national health policy.尼日利亚不孕不育管理综述:制定国家卫生政策的伦理框架。
Int J Womens Health. 2011;3:265-75. doi: 10.2147/IJWH.S20501. Epub 2011 Aug 11.
3
Towards a social discount rate for the economic evaluation of health technologies in Germany: an exploratory analysis.
迈向德国卫生技术经济评估中的社会贴现率:探索性分析。
Eur J Health Econ. 2012 Apr;13(2):127-44. doi: 10.1007/s10198-010-0292-9. Epub 2010 Dec 19.
4
Discounting health effects in pharmacoeconomic evaluations: current controversies.药物经济学评价中对健康影响的贴现:当前争议
Pharmacoeconomics. 2005;23(7):639-49. doi: 10.2165/00019053-200523070-00001.
5
Valuing prevention through economic evaluation: some considerations regarding the choice of discount model for health effects with focus on infectious diseases.通过经济评估重视预防:关于健康影响贴现模型选择的一些考量,重点关注传染病
Pharmacoeconomics. 2004;22(18):1171-9. doi: 10.2165/00019053-200422180-00002.
6
Theoretical arguments for the discounting of health consequences: where do we go from here?健康后果贴现的理论依据:我们将何去何从?
Pharmacoeconomics. 2002;20(14):943-61. doi: 10.2165/00019053-200220140-00001.
7
Economic decision making in healthcare. A standard approach to discounting health outcomes.医疗保健中的经济决策。健康结果贴现的标准方法。
Pharmacoeconomics. 1995 Mar;7(3):198-205. doi: 10.2165/00019053-199507030-00003.
8
Discounting in cost-effectiveness analysis of healthcare programmes.医疗保健项目成本效益分析中的贴现
Pharmacoeconomics. 1993 Apr;3(4):276-85. doi: 10.2165/00019053-199303040-00004.